NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,346,426 | +2822.1% | 3,939,600 | +2722.1% | 0.33% | +2658.3% |
| Q2 2023 | $80,298 | -18.2% | 139,600 | 0.0% | 0.01% | -20.0% |
| Q1 2023 | $98,125 | -73.6% | 139,600 | -15.0% | 0.02% | -72.2% |
| Q4 2022 | $371,069 | -73.0% | 164,190 | -61.8% | 0.05% | -68.0% |
| Q3 2022 | $1,376,000 | -15.8% | 430,037 | 0.0% | 0.17% | -31.9% |
| Q2 2022 | $1,634,000 | -29.5% | 430,037 | 0.0% | 0.25% | -46.6% |
| Q1 2022 | $2,318,000 | -37.4% | 430,037 | +65.4% | 0.46% | -71.9% |
| Q2 2016 | $3,700,000 | +3.5% | 260,000 | 0.0% | 1.65% | +1.3% |
| Q1 2016 | $3,575,000 | -66.0% | 260,000 | -71.5% | 1.63% | -60.7% |
| Q2 2013 | $10,523,000 | – | 911,053 | – | 4.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |